Biontech Q3-regnskab. Nu 13,4 mia € i kassen
-
Vaccine-vinderen fortsætter med at tjene penge. I langsommere tempo end sidste år. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-third-quarter-2022-financial-results-and
De har nu 13,4 mia € i kassen. Det skal sammenholdes med en markedsværdi på 37,45 mia $ (kurs 154). Dvs. mere en tredjedel af aktiernes værdi er til stede i form af kontanter.
Hertil kommer dels indtægter fra fortsat salg af vaccine. Bemærk, at Ugur Sahin lige har været med Scholz i Kina.
Dels værdien af en pipeline, som jeg ikke kan bedømme.
-
BioNTech Q3 Profit Down; Lifts FY22 COVID-19 Vaccine Revenue View
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind